Patents by Inventor Adrian D'Souza

Adrian D'Souza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250138502
    Abstract: An integrated development environment (IDE) leverages a generative AI model to generate industrial control code in accordance with specified functional requirements, which can be provided to the industrial IDE system as intuitive natural language spoken or written text. The industrial IDE can also analyze written code in response to natural language prompts submitted against the code, generate answers to user-submitted questions about the code, and offer recommendations for improving the code in response to specific questions or requests submitted by the user.
    Type: Application
    Filed: October 30, 2023
    Publication date: May 1, 2025
    Inventors: RAHUL PATEL, FABIANO FERNANDES, Christopher E. Stanek, Michael J Ohlsen, ADRIAN D PANTEA, CHRISTOPHER HAYS, ANTHONY CARRARA, Lorenzo P. Majewski, Shawn O Stuart, Kurt E. Mathson, Ashish Anand, MATTHEW J SHEA, ALLEN ROSU
  • Publication number: 20250064963
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: October 18, 2024
    Publication date: February 27, 2025
    Inventors: Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Publication number: 20250064961
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: October 18, 2024
    Publication date: February 27, 2025
    Inventors: Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Publication number: 20250064962
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: October 18, 2024
    Publication date: February 27, 2025
    Inventors: Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Patent number: 12121589
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Grant
    Filed: June 15, 2023
    Date of Patent: October 22, 2024
    Assignee: ABBVIE BIOTHERAPEUTICS INC.
    Inventors: Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Publication number: 20240100181
    Abstract: The present disclosure provides anti-CD19 antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
    Type: Application
    Filed: June 15, 2023
    Publication date: March 28, 2024
    Inventors: Chewei A. Chang, Ethan D. Emberley, Adrian D. Hobson, Christopher C. Marvin, James W. Purcell
  • Patent number: 11876790
    Abstract: A computer-implemented method includes: receiving, by an authentication device, from a client device and via a network device, a plurality of passcode packets as part of a request to be authenticated by the authentication device; recording, by the authentication device, a sequence of port identifiers corresponding to respective ports of the network device via which the plurality of passcode packets are received; and authenticating, by the authentication device, the client device based on the sequence of port identifiers.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: January 16, 2024
    Assignee: THE BOEING COMPANY
    Inventors: Daniel Nguyen, Adrian D. Pirvu, Michael R. Vanguardia
  • Publication number: 20230066771
    Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
    Type: Application
    Filed: July 23, 2021
    Publication date: March 2, 2023
    Inventors: Maria A. Argiriadi, Eric C. Breinlinger, Kevin P. Cusack, Adrian D. Hobson, Dominique Potin, Martine Barth, Jerome Amaudrut, Olivia Poupardin, Laurent Mounier, Michael E. Kort
  • Patent number: 11531954
    Abstract: Described herein are exemplary systems and methods for the optimization of shipping cartons relative to the contents of orders to be placed therein. An exemplary carton optimization method evaluates a sample size of orders received at a given location and then determines an optimal carton set that includes at least one feasible carton for each order, while also minimizing shipping costs based on dimensional weighing-based pricing by reducing the dimensional weight, thereby minimizing void space and increasing the carton space utilization percentage. An exemplary carton optimization method may be further customized to optimize a carton set for an order, based on the cartons already available at a given warehouse or other site. As a result, cartons are utilized and designed more efficiently at the site.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: December 20, 2022
    Assignee: Exel Inc
    Inventors: Adrian D. Kumar, Manjeet Singh, Siqiang Guo
  • Publication number: 20220354959
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 10, 2022
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, Jr., John T. Randolph
  • Publication number: 20220265842
    Abstract: Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R1, R2, and R3 are as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R1, R2, and R3 are as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same.
    Type: Application
    Filed: November 29, 2018
    Publication date: August 25, 2022
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Jason Z. Oh, Michael J. McPherson, Wendy Waegell, Shaughn H. Bryant, Axel Hernandez, Jr., Claire L. Ihle, Christopher C. Marvin, Olivia A. Perng, Ling C. Santora, Lu Wang, Lu Wang
  • Patent number: 11190459
    Abstract: A method, system, and computer program product that includes a processor assigning a network connection to an application, based upon the application requesting the network connection from a pool of network connections for connecting applications to a network resource, the assigned network connection for communicating a message with the network resource. The processor replaces the assigned network connection in the pool with a placeholder comprising configuration data of the assigned connection. The processor determined a period of inactivity of the assigned network connection, and the processor returns the assigned network connection to the pool, based upon the period reaching a defined threshold of inactivity.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: November 30, 2021
    Assignee: International Business Machines Corporation
    Inventors: Adrian D. Dick, Brian C. Homewood, Christopher Matthewson, Craig H. Stirling
  • Publication number: 20210226936
    Abstract: A computer-implemented method includes: receiving, by an authentication device, from a client device and via a network device, a plurality of passcode packets as part of a request to be authenticated by the authentication device; recording, by the authentication device, a sequence of port identifiers corresponding to respective ports of the network device via which the plurality of passcode packets are received; and authenticating, by the authentication device, the client device based on the sequence of port identifiers.
    Type: Application
    Filed: January 21, 2020
    Publication date: July 22, 2021
    Applicant: The Boeing Company
    Inventors: Daniel Nguyen, Adrian D. Pirvu, Michael R. Vanguardia
  • Patent number: 11038030
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: June 15, 2021
    Assignee: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Patent number: 11036527
    Abstract: Embodiments of the present invention disclose a method, computer program product, and system for class splitting in object-oriented environments in which objects are created by classes. Data is analyzed, in response to generating an instance of an original class in a code component. Fields are separated into sets based on the code paths that access the fields. A split class is generated for a set of fields which shares a common interface with the original class. Cells are replaced in the code component to the original class with a split class.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: June 15, 2021
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Adrian D. Dick, Howard J. Hellyer
  • Publication number: 20210130293
    Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
    Type: Application
    Filed: October 16, 2019
    Publication date: May 6, 2021
    Inventors: Maria A. Argiriadi, Eric C. Breinlinger, Kevin P. Cusack, Adrian D. Hobson, Dominique Potin, Martine Barth, Jerome Amaudrut, Olivia Poupardin, Laurent Mounier, Michael E. Kort
  • Publication number: 20210015938
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same.
    Type: Application
    Filed: July 31, 2020
    Publication date: January 21, 2021
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Michael J. McPherson, Wendy Waegell, Christian Goess, Axel Hernandez, Jr., Lu Wang, Lu Wang, Christopher C. Marvin, Ling C. Santora
  • Patent number: 10840114
    Abstract: Apparatus and method for heating a wafer having semiconductor material. The apparatus includes: a chamber, a source of radiant heat; a source of gas; and a susceptor disposed in the chamber to receive and absorb heat radiated by the source of radiant heat; the susceptor having an opening therein to allow a flow of gas to pass from the source of gas to pass through an interior region of the susceptor and over the wafer.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: November 17, 2020
    Assignee: Raytheon Company
    Inventors: Kezia Cheng, Christopher J. MacDonald, Kamal Tabatabaie Alavi, Adrian D. Williams
  • Publication number: 20200338208
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 29, 2020
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, JR., John T. Randolph
  • Publication number: 20200243652
    Abstract: A Field Effect Transistor (FET) having a source, drain, and gate disposed laterally along a surface of a semiconductor and a field plate structure: having one end connected to the source; and having a second end disposed between the gate and the drain and separated from the drain by a gap. A dielectric structure is disposed over the semiconductor, having: a first portion disposed under the second end of the field plate structure; and, a second, thinner portion under the gap.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Applicant: Raytheon Company
    Inventors: Christopher J. MacDonald, Kenneth A. Wilson, Kamal Tabatabaie Alavi, Adrian D. Williams